Efrain Lazcano-Ibarra

Passionate, Driven and Loyal individual that loves his wife and daughters to the fullest!

[ArteraAI @arteraAI]

We’re proud our parnter @ZEROCancer is raising national awareness around prostate cancer screening during the #SuperBowl.

Early detection starts with a simple PSA test, and changing the conversation can change outcomes.

https://t.co/RIS451kq40

#MensHealth #RelaxItsABloodTest

[ArteraAI @arteraAI]

Snowstorms in Vail. Sunshine in Florida.

Grateful for quality time with the community at both #IPCU2026 and #ACRO2026 last week.

Thanks to everyone who joined us, always inspired by the conversations driving cancer care forward.

#ArteraAI #Oncology

[ArteraAI @arteraAI]

Catch the Artera team at both the @MayoClinic Urology Review in Kamuela, HI and the Aspen Urological Conference in Aspen, CO.

Let’s talk AI, innovation & prostate cancer care. See you there!
#Urology #ProstateCancer #ArteraAI

[ArteraAI @arteraAI]

Attending #ACRO2026? Don’t miss Dr. Douglas Rivera and Dr. Ben Fischer-Valuck in a case-based session on using the ArteraAI Prostate Test in localized prostate cancer care.

Register: https://t.co/qEF6upquuZ

#ArteraAI

[ArteraAI @arteraAI]

Grateful to @UroToday, Dr. Paul Nguyen, and Dr. Zach Klaassen for highlighting our AI-powered prognostic test in the salvage radiation therapy setting.

Watch the full interview: https://t.co/8LFS7mc7ju

#ProstateCancer #ArteraAI

[ArteraAI @arteraAI]

Excited to join the 2026 @IowaUrology Annual Conference in Galena, IL! Looking forward to connecting with the UCI team to talk AI + precision care in urology.

#Urology #ArteraAI #ProstateCancer

[ArteraAI @arteraAI]

Dr. Daniel Spratt on Artera’s Post‑RP test:

“[It] uses clinical and pathologic features + digital pathology, running AI to help ID patients at low vs high risk of recurrence and metastasis.”

Thanks @UroTimes + Hannah Clarke for the feature.

https://t.co/81ShDfFaKT

#ArteraAI

[ArteraAI @arteraAI]

Recently published in @EUplatinum!
Study led by Dr. Todd Morgan supports the utility of the ArteraAI Prostate Test (Post-RP) in guiding care for patients with biochemical recurrence.

https://t.co/C5QzUEnb7P

#ProstateCancer #ArteraAI #DigitalPathology #Urology

[ArteraAI @arteraAI]

See you in Utah! The Artera team is excited to attend the @UrologyUS Global Prostate Cancer Congress and share how AI is helping improve care across the prostate cancer journey. #GPCCongress #ProstateCancer #ArteraAI

[ArteraAI @arteraAI]

Excited to join the Mayo Clinic Radiation Oncology Course in Kauai January 5-9, 2026! Looking forward to great discussions on the future of prostate cancer care. #RadiationOncology #ArteraAI

[ArteraAI @arteraAI]

2025 was a milestone year for Artera: innovation, clinical impact, and recognition for AI-driven oncology. From FDA authorizations and major trials to CEO Andre Esteva in TIME 100, we’re proud of the progress, and excited to expand into breast cancer in 2026.

[ArteraAI @arteraAI]

We’re proud to see @UroToday highlight the commercial launch of the ArteraAI Prostate Test (Post-RP), expanding our oncology portfolio to support patients experiencing biochemical recurrence after radical prostatectomy: https://t.co/H5xQ8pNKt8

[ArteraAI @arteraAI]

The Artera team had a great time at #SABCS25!
Excited by the momentum around AI-driven diagnostics and their potential to advance precision care in oncology.

#BreastCancer #Oncology #ArteraAI #PrecisionMedicine

[ArteraAI @arteraAI]

We’re heading to Florida for #FUS2025! Excited to connect with the urology community and share how the ArteraAI Prostate Test is helping personalize prostate cancer treatment decisions.

#Urology #ProstateCancer #AIinHealthcare #ArteraAI #PrecisionMedicine

[ArteraAI @arteraAI]

This Thanksgiving, we’re thankful for:
🧠 Research collaborators
🩺 Clinicians using our tools
💙 The patients we serve
🤝 Partners like CorePlus & @PathNetLab

Grateful to work alongside you in advancing personalized prostate cancer care.

#ArteraAI #AIinHealthcare

[ArteraAI @arteraAI]

We are excited to share 3 key data presentations at @SABCS, showcasing the validation of our #MMAI model in early-stage #breastcancer across multiple Phase III trials in over 12,000 patients from across the world.

Read more here:
https://t.co/7lDurtCHdq

[ArteraAI @arteraAI]

We’re headed to Phoenix for #SUO2025 this December 2-5!

Looking forward to connecting with urologic oncology experts and sharing how Artera is helping personalize prostate cancer care with AI.

#ArteraAI #UrologicOncology #ProstateCancer #PrecisionMedicine

[ArteraAI @arteraAI]

We’re heading to Chicago for #LUGPA2025 this November!

Excited to connect with independent urology leaders and share how Artera is supporting smarter, faster prostate cancer decisions with AI.

#ArteraAI #Urology #ProstateCancer #PrecisionMedicine @LUGPA

[ArteraAI @arteraAI]

Prostate cancer affects everyone differently. AI can help doctors spot patterns in biopsy images to guide decisions, like whether short-term ADT with radiation may help. Because cancer is personal, therapy should be too.

Learn more in this summary of our predictive validation:

[ArteraAI @arteraAI]

New from @UrologyTimes: A recent validation study shows #MMAI model performs consistently in Asian patients with localized prostate cancer.

Read the article: https://t.co/PRQsyEmvEV

#ArteraAI #ProstateCancer #HealthEquity